Publisher: Icon Group International, Inc.
Category: Generics Drugs

Generics Drugs market research reports by Icon Group International, Inc.

(17 reports matching your criteria)
    • The 2025-2030 World Outlook for Cold-Chain Generic Drugs

      The 2025-2030 World Outlook for Cold-Chain Generic Drugs This study covers the world outlook for cold-chain generic drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More

    • The 2025-2030 World Outlook for Inhalation and Nasal Spray Generic Corticosteroid Drugs

      The 2025-2030 World Outlook for Inhalation and Nasal Spray Generic Corticosteroid Drugs This study covers the world outlook for inhalation and nasal spray generic corticosteroid drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential indu ... Read More

    • The 2025-2030 World Outlook for Influenza Medications

      The 2025-2030 World Outlook for Influenza Medications This study covers the world outlook for influenza medications across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More

    • The 2025-2030 World Outlook for Generic Injectables

      The 2025-2030 World Outlook for Generic Injectables This study covers the world outlook for generic injectables across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More

    • The 2025-2030 World Outlook for Generics in Antivirals

      The 2025-2030 World Outlook for Generics in Antivirals This study covers the world outlook for generics in antivirals across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More

    • The 2025-2030 World Outlook for Generic Prescription Drugs

      The 2025-2030 World Outlook for Generic Prescription Drugs This study covers the world outlook for generic prescription drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More

    • The 2025-2030 World Outlook for Generic Oncology Drugs

      The 2025-2030 World Outlook for Generic Oncology Drugs This study covers the world outlook for generic oncology drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More

    • The 2025-2030 World Outlook for Generic Drugs

      The 2025-2030 World Outlook for Generic Drugs This study covers the world outlook for generic drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), t ... Read More

    • The 2025-2030 World Outlook for Generic Biosimilars

      The 2025-2030 World Outlook for Generic Biosimilars This study covers the world outlook for generic biosimilars across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More

    • The 2025-2030 World Outlook for Branded Generics

      The 2025-2030 World Outlook for Branded Generics This study covers the world outlook for branded generics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dolla ... Read More

    • The 2025-2030 World Outlook for Specialty Generics

      The 2025-2030 World Outlook for Specialty Generics This study covers the world outlook for specialty generics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. d ... Read More

    • The 2025-2030 World Outlook for Inhalation and Nasal Spray Generic Drugs

      The 2025-2030 World Outlook for Inhalation and Nasal Spray Generic Drugs This study covers the world outlook for inhalation and nasal spray generic drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for th ... Read More

    • The 2025-2030 World Outlook for Generic Biosimilar Large Molecule Injectables

      The 2025-2030 World Outlook for Generic Biosimilar Large Molecule Injectables This study covers the world outlook for generic biosimilar large molecule injectables across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E ... Read More

    • The 2025-2030 World Outlook for Generic Antiviral Drugs

      The 2025-2030 World Outlook for Generic Antiviral Drugs This study covers the world outlook for generic antiviral drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More

    • The 2025-2030 World Outlook for Specialty Injectable Generics

      The 2025-2030 World Outlook for Specialty Injectable Generics This study covers the world outlook for specialty injectable generics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question ... Read More

    • The 2025-2030 World Outlook for Pure Generic Drugs

      The 2025-2030 World Outlook for Pure Generic Drugs This study covers the world outlook for pure generic drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. d ... Read More

    • The 2025-2030 World Outlook for Generic Inhalation and Nasal Spray Drugs

      The 2025-2030 World Outlook for Generic Inhalation and Nasal Spray Drugs This study covers the world outlook for generic inhalation and nasal spray drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for th ... Read More

Research Assistance

Live help

Join Alert Me Now!

Sign Up

Find out more on our blog
Cookie Settings